Advertisement

Topics

Immunotherapies may increase overall survival in patients with melanoma brain metastases

00:00 EDT 13 Jul 2018 | News-Medical.net

Among patients with cutaneous melanoma who had brain metastases (MBM), first-line treatment with a checkpoint inhibitor was associated with a 1.4-fold increase in median overall survival, according to results from a national cohort.

Original Article: Immunotherapies may increase overall survival in patients with melanoma brain metastases

NEXT ARTICLE

More From BioPortfolio on "Immunotherapies may increase overall survival in patients with melanoma brain metastases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....